A RANDOMIZED, OPEN-LABEL, SINGLE-DOSING, 2X2 CROSSOVER STUDY TO COMPARE THE SAFETY AND PHARMACOKINETICS OF BR-TND TABLET(TENOFOVIR DISOPROXIL) WITH VIREAD TABLET(TENOFOVIR DISOPROXIL FUMARATE) IN HEALTHY MALE VOLUNTEERS: